AI investment in biopharma is expected to increase 600% by 2030, yet 90.5% of life sciences orgs struggle with multimodal data storage, slowing discovery. TileDB Carrara was designed to navigate the perfect storm of multimodal data. Learn more 👇 hubs.ly/Q03HsTjT0

🚀 Don't miss our October 2 Tech Talk! We're unveiling TileDB Carrara - the multimodal database designed for discovery. Hear from TileDB leadership about the vision behind Carrara and how it empowers scientific teams to accelerate breakthroughs. RSVP 👇 hubs.la/Q03HN0Tf0

You know there's a problem when data management eats up more of your day than actual research. TileDB Carrara transforms this chaos into unified data you can work with in minutes. Kyle O'Shea, Senior Product Manager at TileDB, explains more 👇 hubs.la/Q03J70nB0

Is your team's data infrastructure ready for the next phase of scientific discovery? Take our 5-minute Multimodal Data Maturity Assessment to discover next steps for integration & FAIR compliance. hubs.la/Q03JZh7s0

⌛ Only a few days until our Tech Talk unveiling TileDB Carrara - the solution to your multimodal data chaos. Join us to hear from TileDB's leadership about Carrara's omnimodal vision, architecture, and how it streamlines data-intensive R&D work. RSVP 👇 hubs.la/Q03K_20r0

How much research time is wasted because scientists can't reproduce each other's work? Jeremy Leipzig identifies metadata as "the glue of reproducibility" — often missing from research workflows. TileDB Carrara aims to solve this. Follow the conversation ⬇️ hubs.la/Q03L6Dr10

⏰ 2 days to register for our October 2nd Tech Talk! Join us as we unveil TileDB Carrara—the multimodal database built to end data chaos and accelerate discovery. Live-only bonus: 7-Week Omnimodal Action Plan 📅 Oct 2 | 1:00 PM ET RSVP: hubs.la/Q03Lw7H50

🎉 Today, we are announcing TileDB Carrara—the first omnimodal data intelligence platform. Carrara's future-ready architecture unifies all data types (genomics, imaging, documents, tables, and more) in one governed environment built for AI-era analytics. hubs.la/Q03MybyQ0

What are multimodal databases, and how do they work? What are their benefits and uses? How do they serve multimodal AI? How to choose the best one for your needs? Our comprehensive guide covers all this and more. 👇 hubs.la/Q03MJh350

We're partnering with Kepler AI and Tahoe Therapeutics to launch the first platform for AI agent queries on massive single-cell datasets. Pharma and biotech teams can now use Tahoe-100M with their data to train models or run real-time queries. hubs.ly/Q03MX-sW0

Fragmented technology stacks are preventing organizations from achieving unified multimodal analysis. 📖 From our latest report: 𝘛𝘩𝘦 𝘚𝘵𝘢𝘵𝘦 𝘰𝘧 𝘔𝘶𝘭𝘵𝘪𝘮𝘰𝘥𝘢𝘭 𝘋𝘢𝘵𝘢 𝘪𝘯 𝘉𝘪𝘰𝘵𝘦𝘤𝘩 & 𝘗𝘩𝘢𝘳𝘮𝘢 2025 hubs.la/Q03N3-W-0

Multiomics analysis has transformed biology, but technical complexity overshadows the science. TileDB Carrara unifies fragmented workflows—from reference files to Nextflow pipelines to exploration—in one compliant environment. See how ⬇️ hubs.la/Q03NGjdD0

James Gatter, Software Engineer at Cellarity, shares how TileDB Carrara's omnimodal approach enhances their drug discovery mission. Learn more about TileDB Carrara ⬇️ hubs.la/Q03NTTSz0

💡 What is single-cell sequencing? 💡 How does it differ from bulk RNA-seq? 💡 What are the costs and benefits? Complete guide to Single-Cell Sequencing ⬇️ hubs.la/Q03PHK200